Similar Articles
Efficacy and Safety of Opinercept Tumor Necrosis Factor Inhibitor Therapy for Drug-Refractory Rheumatoid Arthritis: A Randomized Clinical Trial
Toong-Hua LIANG, Chyou-Shen LEE, Shinn-Shing LEE, Chien-Sheng WU, Kun-Hung CHEN, Ping-Ning HSU, Hsiao-Yi LIN
DOI: 10.46497/ArchRheumatol.2020.7464
The Relationship Between Serum Angiogenic Factor Levels and Disease Activity in Rheumatoid Arthritis
Zahide ASLANALP, Canan TIKIZ, Aslıhan ULUSOY, Şebnem ORGUC, Aysun BİLGİ YEDEKCİ, Cevval ULMAN
DOI: 10.46497/ArchRheumatol.2020.7416
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry
Marco SEBASTIANI, Andreina MANFREDI, Florenzo IANNONE, Elisa GREMESE, Alessandra BORTOLUZZI, Ennio FAVALLI, Chiara BAZZANI, Fausto SALAFFI, Enrico FUSARO, Rosario FOTI, Chiara GIANNITTI, Roberto CAPORALI, Alberto CAULI, Giulia CASSONE, Giuseppe LOPALCO, Luca PETRICCA, Gianfranco FERRACCIOLI, Giovanni LAPADULA
DOI: 10.46497/ArchRheumatol.2020.7499
Self-Reported Medication Adherence in Patients With Ankylosing Spondylitis: The Role of Illness Perception and Medication Beliefs
Sena TOLU, Aylin REZVANİ, İlhan KARACAN, Derya BUGDAYCI, Habib Can KÜÇÜK, Ömer Faruk BUCAK, Teoman AYDIN
DOI: 10.46497/ArchRheumatol.2020.7732
The Correlations Between Disease Specific Quality of Life, Short Form-36 and Clinical Variables in Patients With Ankylosing Spondylitis
Hakan ALKAN, Necmettin YILDIZ, Füsun ARDIÇ
DOI: 10.46497/ArchRheumatol.2020.7750
Does Abatacept Induce Testicular Toxicity?
Sultan AL-MOGAIREN
DOI: 10.46497/ArchRheumatol.2020.7164
Serum C-Reactive Protein/Albumin Ratio in Rheumatoid Arthritis and its Relationship With Disease Activity, Physical Function, and Quality of Life
İsmihan SUNAR, Şebnem ATAMAN
DOI: 10.46497/ArchRheumatol.2020.7456
Spontaneous Spinal Epidural Hematoma During Simultaneous Tocilizumab and Warfarin Use in a Patient With Rheumatoid Arthritis: Is There a Drug Interaction Between Tocilizumab and Oral Anticoagulants?
Seçilay GÜNEŞ, Haydar GÖK, Şebnem ATAMAN, Şehim KUTLAY
DOI: 10.46497/ArchRheumatol.2020.7579
Obesity and Remission Rates in Japanese Patients With Rheumatoid Arthritis Requiring Anti-Tumor Necrosis Factor Alpha Therapy
Kenji YAMAZAKI, Etsuji SUZUKI, Ryuhei ISHIHARA, Toshiaki MIYAMOTO
DOI: 10.46497/ArchRheumatol.2020.7852
Biomarkers of Cardiovascular Disease in Patients With Ankylosing Spondylitis
Ümit SARP, Evren ÜSTÜNER, Sehim KUTLAY, Şebnem ATAMAN, Sim KUTLAY
DOI: 10.46497/ArchRheumatol.2020.7868
Change of ARASHI scores for large joints in rheumatoid arthritis patients treated with abatacept for three years: A clinical observational study
Takeshi MOCHIZUKI, Koichiro YANO, Katsunori IKARI, Ryo HIROSHIMA, Mina ISHIBASHI, Ken OKAZAKI
DOI: 10.46497/ArchRheumatol.2021.7727
Knowledge of cardiovascular disease risk in rheumatoid arthritis patients before and after educational intervention from a Southeast Asia country: Malaysia
Boon Ching TEOH, Syed Azhar SYED SULAIMAN, Bee Eng TAN
DOI: 10.46497/ArchRheumatol.2021.7726
Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks
Murat KARKUCAK, Mehmet KOLA, Ahmet KALKIŞIM, Erhan ÇAPKIN, Ahmet AYAR, Adem TÜRK
DOI: 10.46497/ArchRheumatol.2021.7806
Joint Surgery in Tunisian Rheumatoid Arthritis Patients: Prevalence and Risk Factors
Olfa SAIDANE, Leila GAFSI, Aicha Ben TEKAYA, Ines MAHMOUD, Rawdha TEKAYA, Leila ABDELMOULA
DOI: 10.46497/ArchRheumatol.2020.7483
A cross-sectional study of sexual dysfunction in chinese mainland female patients with rheumatoid arthritis
Congcong ZHOU
DOI: 10.46497/ArchRheumatol.2021.8074
Patients with rheumatoid arthritis and osteoarthritis in terms of sex hormone receptors and histopathological comparison of features
Turgut KÜLTÜR, Mehmet ZENGİN
DOI: 10.46497/ArchRheumatol.2021.8242
Evaluating various radiographic methods of shoulder joint damage in patients with rheumatoid arthritis receiving biological disease-modifying antirheumatic drugs
Kazuhito Sugimori, Isao Matsushita, Tomoatsu Kimura
DOI: 10.46497/ArchRheumatol.2021.8236
Kinesiophobia in rheumatoid arthritis patients: Relationship with quadriceps muscle strength, fear of falling, functional status, disease activity, and quality of life
İlkay Baysalhan Öztürk, Yeşim Garip, Filiz Sivas, Merve Parlak Özden, Hatice Bodur
DOI: 10.46497/ArchRheumatol.2021.8535
Attitudes of patients with spondylarthritis or rheumatoid arthritis regarding biological treatment during COVID-19 pandemic: A multi-center, phone-based, cross-sectional study
Coskun Zateri, Murat Birtane, İlknur Aktaş, Selda Sarıkaya, Aylin Rezvani, Lale Altan, Nigar Dursun, Erbil Dursun, Nurettin Taştekin, Reyhan Çeliker, Şenay Özdolap, Kenan Akgün
DOI: 10.46497/ArchRheumatol.2021.8364
Patient perspectives on biological treatments for inflammatory arthritis: A multi-center study in Korea
In Ah Choi, Ji Hyoun Kim, Sung Hae Chang, Ran Song, You-Jung Ha, Hye Won Kim, Jeong Seok Lee, Byoongyong Choi, Yoon-Jeong Oh, Ki Won Moon
DOI: 10.46497/ArchRheumatol.2021.8524